Adeno-associated viruses (AAV) are promising vectors for in vivo gene therapy. They can deliver a genetic payload of up to 4.7 kb ...
Under intense pressure to develop cell and gene therapies on tight timelines, biotech companies are encountering common ...
The adeno-associated virus (AAV) is a powerful vehicle for gene therapy; however, working with AAV vectors can be challenging. ...